Tag Archives: Iquum

Disruptive Innovation in Molecular Diagnostics – IQuum

In my previous blog series, Strategic Planning for New Ventures, I showcased an example of a disruptive innovator in Veracyte, leader in thyroid cancer diagnostics.   Veracyte pursues the specialized CLIA lab business model, offering a unique, high-value test that cannot be obtained elsewhere. In this blog, I profile another innovator, IQuum, which is pursuing the other common model in molecular

Read more